After finding success with a weight management program, BlueCross BlueShield of South Carolina expanded its employee wellness program developed by Solera Health to include mental health and musculoskeletal services.

The New York State Office for the Aging announced Wednesday that it is partnering with Intuition Robotics to bring an AI robotic care companion into the homes of 800 older adults as part of the state’s efforts to battle social isolation and support aging in place.

The company’s AI-enabled imaging software identifies a suspected pulmonary embolism and delivers real-time notifications to physicians so the patient can be treated quickly.

The startup’s Cordella Pulmonary Artery Pressure Sensor System, which was implanted in 70 heart failure patients in Europe, led to low hospitalization rates and high patient compliance with daily measurements needed to monitor them remotely.

The startup—which has twice received KLAS Research’s “Best in KLAS” award for patient outreach—will use funds its raised to grow the number of teams working on its patient communication solutions.

The Dublin-based pathology software and services provider will use the funds to support global growth and launch an on-demand, online pathology service in the U.S.

A new survey finds it’s not just clinical staff but administrative positions that are going unfilled causing further pressure on health systems and forcing them to spend more on overtime and contractor pay.

Mahmee raised $9.2 million in Series A funding led by Goldman Sachs Asset Management. The startup’s CEO, Melissa Hanna, saw the raise as clear recognition of the progress Mahmee has made in tackling disparities in maternal care.

The Boston-based company announced Monday that it had received 510(k) clearance from the FDA for its Caries Assist, software that uses AI to aid dentists in detecting cavities. In May last year, Overjet received FDA clearance for AI-powered technology used in the diagnosis and treatment of gum disease.

To get approval for the deal, Medtronic agreed to sell an Intersect subsidiary to soothe the FTC’s concerns.

Early detection and treatment of heart failure can greatly improve an otherwise poor prognosis. Research from Mayo Clinic suggests artificial intelligence could be used to detect the condition even when no symptoms are present.

The Dublin, Ireland-based device maker has the first system cleared by the FDA that uses artificial intelligence to detect potential signs of colon cancer. Research recently suggested that combined with colonoscopy, AI could improve colon cancer prevention and reduce costs for patients.

Pulling back the curtain on healthcare pricing is easier said than done, acknowledged Chris Severn, the company’s co-founder and CEO. That’s exactly why the investment is so important.

The Series B funding round was led by DFJ Growth. Osmind helps the medical community administer treatments, and track and study the effectiveness of those treatments for 14 million U.S. patients living with moderate and serious mental illness, according to the company.

The startup’s asthma solution, called Mya, combines home-based diagnostics, digital health and a care team to identify patients at risk and proactively intervene to prevent asthma attacks.

The Allston, Massachusetts-based health tech startup is looking to help people on Medicaid not only quit smoking but also make other behavioral changes that will improve their overall health. Its platform offers everything from financial incentives to personalized coaching.

To supplement the counseling services Magellan Federal offers to service members and their spouses, NeuroFlow will provide access to resources and support through its app.

Startup iSono Health said its FDA-cleared automated imaging system will make personalized whole breast imaging more accessible to women worldwide and could help improve breast cancer diagnosis.

Full EHR interoperability and data standardization remain the holy grail: mysterious and elusive. So hospitals are employing different strategies to access a patient’s complete medical history.

The Series D funding round was led by growth equity firm Stripes. Hello Heart’s latest haul brings the total amount the company has raised since its founding in 2013 to $138 million.

Ceryx’s device, Cysoni, is designed to pace the heart in rhythm with a person’s respiration, so that the heart rate and breathing are synced. This is typically the case for a healthy person, but for someone with heart failure, that link becomes severed, CEO Stuart Plant said.

The San Diego-based behavioral health medical group announced Wednesday that it has raised $42 million in Series B financing led by Define Ventures. The company currently partners with primary care, pediatric care and women’s health groups in 11 states to integrate mental healthcare.

Pharmacy benefit managers have been widely criticized for opaque drug pricing practices. But Waltz Health, which was co-founded by former PBM executive Mark Thierer, aims to use insider knowledge and tech solutions to lower drug costs.

The voice solution Suki Assistant uses machine learning and natural language processing to accurately understand and document information and respond to physician commands, according to the company.

NexHealth raised $125 million in a Series C funding round that was led by Buckley Ventures, the patient experience platform announced Thursday. The latest investment brings the company’s valuation to $1 billion.

Wallaby, which has its main offices in Laguna Hills, California and Shanghai, China, and Bochum, Germany-based phenox have been strategic partners since 2019. The deal is valued at about 500 million euros, including milestone payments, or the equivalent of more than $542 million.

Clinton, Missouri-based Golden Valley Memorial Healthcare is the first to deploy Meditech’s solution, Expanse Genomics. It allows providers to analyze and parse genetic results into actionable data that is displayed directly in patient charts, according to Meditech.

The program, called Digital Bridge, will leverage Icario’s expertise in personalized health communications to help plans ensure members are able to access resources available to get low-cost or free broadband.

The company touts its personalized approach to helping patients who need the most support with medications, like those who are managing multiple health conditions.

The company has $20 million in funding, including $16 million from a Series A funding round announced Wednesday, and backing from the veteran health executive who has already been at the helm of two startups-turned-unicorns.